Omeprazol Teva-Ratio (Omeprazole)

Omeprazole, the active ingredient in Omeprazol Teva-Ratio, is a Proton‑Pump Inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat acid‑related disorders in adults and children.

GNH USA supplies Omeprazol Teva‑Ratio as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole acts on the gastric acid secretion pathway and is indicated for several acid‑related conditions. - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive esophagitis. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion. - Helicobacter pylori eradication regimens: used as adjunct therapy to improve eradication rates. - NSA‑related gastric protection: lowers risk of ulcer formation in high‑risk patients.

Adverse reactions to omeprazole are generally mild to moderate and vary with duration of therapy.

Common Side Effects: - Headache: mild, transient headache reported in clinical use. - Diarrhea: loose stools occurring especially during the first weeks. - Nausea: occasional feeling of queasiness. - Abdominal pain: mild discomfort in the upper abdomen. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements in some patients.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis linked to altered gut flora. - Osteoporosis‑related fractures: increased risk of hip, wrist or vertebral fractures with long‑term use. - Acute interstitial nephritis: sudden kidney inflammation. - Severe hypersensitivity: rash, angioedema or anaphylaxis. - Vitamin B12 deficiency: reduced absorption with prolonged therapy.

When prescribing omeprazole, clinicians should consider several safety aspects. - Assess renal and hepatic function: dose adjustment may be needed in severe impairment. - Review concomitant medications: potential for drug‑drug interactions. - Monitor long‑term users: watch for bone density loss and micronutrient deficiencies. - Use the lowest effective dose: limit duration to the shortest period required. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Omeprazole can affect the pharmacokinetics of several medicines, requiring attention to interaction risk.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular event risk. - Atazanavir/ritonavir: decreased antiviral plasma levels, compromising HIV therapy. - Warfarin: enhanced anticoagulant effect, raising bleeding risk.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum concentrations, may require dose adjustment. - Methotrexate: reduced clearance, risk of toxicity. - Phenytoin: altered metabolism, may affect seizure control.